Valore202020212022202320242025TTMSpese di vendita, generali e amministrative3.18 B3.32 B2.76 B2.84 B2.93 B3.26 B3.26 BRicerca e sviluppo372 M497.2 M406 M458.7 M437.4 M458.5 M458.5 MReddito operativo-87.8 M780.1 M696.3 M1.28 B1.29 B1.1 B1.1 BProventi non operativi, Totale2.6 M8.1 M-239.3 M-28.4 M-57.2 M26 M11.3 MOneri finanziari, al netto degli interessi capitalizzati———————Proventi non operativi, esclusi gli oneri finanziari-22.8 M-3.7 M-111.3 M-19.1 M-26.1 M500 K-14.2 MEntrate/uscite straordinarie25.4 M11.8 M-128 M-9.3 M-31.1 M25.5 M25.5 MUtile al lordo delle imposte-274.4 M418.4 M403.5 M1.07 B1.04 B830.8 M830.8 MQuota di utile———————Imposte-137 M16.3 M112.3 M42.2 M131.4 M125.7 M125.7 MInteressi di minoranza1.5 M500 K—————Altri proventi/oneri al netto delle imposte———————Utile netto al lordo delle attività cessate-138.9 M401.6 M290.2 M1.08 B962.6 M705.1 M705.1 MAttività cessate——-58.8 M-58.8 M-58.8 M——Utile netto-138.9 M401.6 M231.4 M1.02 B903.8 M705.1 M705.1 MRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari-138.9 M401.6 M231.4 M1.02 B903.8 M705.1 M705.1 MUtile base per azione (EPS base)-0.671.931.14.914.453.563.56Utile diluito per azione (EPS diluito)-0.671.911.14.884.433.553.55Numero medio di azioni ordinarie in circolazione207 M208.6 M209.6 M208.7 M203.1 M198 M792.9 MAzioni diluite in circolazione207 M210.4 M210.3 M209.7 M203.9 M198.7 M795.5 MEBITDA732.9 M1.64 B1.46 B2.03 B2.06 B1.9 B1.9 BEBIT-299.8 M571.7 M531.5 M1.08 B1.07 B805.3 M805.3 MCosto del fatturato2.13 B2.34 B2.02 B2.08 B2.19 B2.49 B2.49 BAltri costi del venduto250 M181.7 M137.3 M155.2 M149.9 M311.2 M—Ammortamento e svalutazione (liquidità)1.03 B1.07 B926.4 M951.7 M996.3 M1.09 B1.09 B
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.